Stock Price
2,586.00
Daily Change
38.00 1.49%
Monthly
5.04%
Yearly
27.51%
Q1 Forecast
2,460.05



Peers Price Chg Day Year Date
ABB 66.90 0.46 0.69% 34.66% Feb/06
Arendals Fossekompani 149.00 -3.00 -1.97% 14.62% Feb/06
Assa Abloy 394.60 6.60 1.70% 21.08% Feb/06
Atlas Copco 187.95 0.60 0.32% 2.34% Feb/06
Bonheur 262.00 0 0% 6.94% Feb/06
Electrolux 83.56 1.56 1.90% -11.52% Feb/06
Halma 3,548.00 26.00 0.74% 23.97% Feb/06
IMI 2,844.00 44.00 1.57% 48.59% Feb/06
Intracom Holdings 3.46 -0.08 -2.12% 16.53% Feb/06
KONE 60.04 -3.52 -5.54% 21.05% Feb/06

Indexes Price Day Year Date
GB100 10370 60.53 0.59% 19.19% Feb/06
EU600 617 5.47 0.89% 13.70% Feb/06

Smiths traded at 2,586.00 this Friday February 6th, increasing 38.00 or 1.49 percent since the previous trading session. Looking back, over the last four weeks, Smiths gained 5.04 percent. Over the last 12 months, its price rose by 27.51 percent. Looking ahead, we forecast Smiths to be priced at 2,460.05 by the end of this quarter and at 2,316.09 in one year, according to Trading Economics global macro models projections and analysts expectations.

Smiths Group plc is a technology company. The Company operates in five divisions: John Crane, Smiths Detection, Flex-Tek, Smiths Interconnect and Smiths Medical. John Crane provides mission-critical solutions such as mechanical seals, seal support systems, power transmission couplings and filtration systems for global energy and process industries. Smiths Detection produces detection and screening technologies for the identification of safety and security threats. Flex-Tek provides engineered components that heat and move fluids and gases for aerospace, consumer products, construction, medical and industrial applications. Smiths Interconnect provides electronic components, subsystems, microwave and radio frequency products that provide secure connectivity of critical applications in the defense, aerospace, communications and industrial markets. Smiths Medical offers medical devices and consumables in the select segments of the infusion systems, vascular access and vital care markets.